REQUEST A DEMO
Total
USD $0.00
Search more companies

Epilepsy Research S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Other Ambulatory Health Care Services
Full name: Epilepsy Research S.A.S. Profile Updated: June 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Epilepsy Research S.A.S. is an enterprise based in Colombia. Its main office is in Cali. It operates in the Ambulatory Health Care Services sector. It was established on May 27, 2024. Epilepsy Research S.A.S. currently employs 1 (2026) people. From the latest financial highlights, Epilepsy Research S.A.S. reported a net sales revenue increase of 138.6% in 2025. During that time, Epilepsy Research S.A.S.’s total assets grew by 90.7%. The net profit margin of Epilepsy Research S.A.S. decreased by 6.82% in 2025.

Headquarters
Cr 37 3 Bis 05 Ca 14 Urb Santa Maria de los Farallones
Cali; Valle del Cauca;

Contact Details: Purchase the Epilepsy Research S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Epilepsy Research S.A.S. report to view the information.
Financial Auditors:
Purchase the Epilepsy Research S.A.S. report to view the information.
Incorporation Date:
May 27, 2024
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Epilepsy Research S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
138.6%
Total Operating Revenue
138.6%
Operating Profit
136.13%
Net Profit/Loss for the Period
114.45%
Total Assets
90.7%
Total Equity
214.41%
Operating Profit Margin
-0.77%
Net Profit Margin
-6.82%
Return on Equity (ROE)
-31.79%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?